SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Ripple is the catchall name for the cryptocurrency platform, the transactional protocol for which is actually XRP, in the same fashion as Ethereum is the name for the platform that facilitates trades in Ether. Like other cryptocurrencies, Ripple is built atop the idea of a distributed ledger network which requires various parties to participate in validating transactions, rather than any singular centralized authority. That facilitates transactions all over the world, and transfer fees are far cheaper than the likes of bitcoin. Unlike other cryptocurrencies, XRP transfers are effectively immediate, requiring no typical confirmation time.  Ripple was originally founded by a single company, Ripple Labs, and continues to be backed by it, rather than the larger network of developers that continue bitcoin’s development. It also doesn’t have a fluctuating amount of its currency in existence. Where bitcoin has a continually growing pool with an eventual maximum, and Ethereum theoretically has no limit, Ripple was created with all of its 100 billion XRP tokens right out of the gate. That number is maintained with no mining and most of the tokens are owned and held by Ripple Labs itself — around 60 billion at the latest count.  Even at the recently reduced value of around half a dollar per XRP, that means Ripple Labs is currently sitting on around $20 billion worth of the cryptocurrency (note: Ripple’s price crashed hard recently, and may be worth far less than $60 billion by time you read this). It holds 55 billion XRP in an escrow account, which allows it to sell up to a billion per month if it so chooses in order to fund new projects and acquisitions. Selling such an amount would likely have a drastic effect on the cryptocurrency’s value, and isn’t something Ripple Labs plans to do anytime soon.  In actuality, Ripple Labs is looking to leverage the technology behind XRP to allow for faster banking transactions around the world. While Bitcoin and other cryptocurrencies are built on the idea of separating financial transactions from the financial organizations of traditional currencies, Ripple is almost the opposite in every sense.  XRP by Ripple price can be found on this page alongside the market capitalization and additional stats.

Ripple

XRP is trending as the broader crypto market faces a downturn, intensified by concerns over a hawkish Fed Chair nomination, even as proponents highlight progress on regulatory clarity through the Digital Commodity Intermediaries Act. The community is sharply divided, with many accumulating on dips while others voice frustration over perceived manipulation and stagnant price action.

Luckin Coffee, Inc. engages in providing food and beverage items, and operates coffee retail stores. It has a pioneered a technology-driven retail network to provide coffee and other products of high quality, high convenience and high affordability to customers. The company manages pick-up stores, relax stores, and delivery kitchens. It also offers tea, snacks, and light meals through its mobile application. The company was founded by Zhi Ya Qian, Fei Yang and Jin Yi Guo on June 16, 2017 and is headquartered in Xiamen, China.

Luckin Coffee Inc - ADR

Luckin Coffee is trending as competitor Cotti Coffee ends aggressive pricing, setting the stage for improved profitability, while investors keenly compare its hyper-growth and superior fundamentals against Starbucks, fueling community discussion around its rapid global expansion and the anticipated uplisting from the OTC market.

Bankr is an advanced AI agent focused on simplifying the process of buying and selling digital assets. Bankr was the first AI agent on Farcaster to help you quickly buy all your favorites coins directly in the social. BankrCoin is the official coin of the agent and was deployed by Bankr itself directly in the Farcaster social feed. Fees from swaps go to support BankrCoin. Bankr is available on Farcaster and will soon be launching a private terminal, token recs, and limit orders on Base.

BankrCoin

BankrCoin (BNKR) is trending amidst claims of AI-powered utility and deep integration within the Coinbase Base ecosystem, igniting a fervent community debate between those predicting a parabolic ascent and others warning of a rapid pump-and-dump.

Ethereum is a global, open-source platform for decentralized applications. In other words, it is a decentralized blockchain platform that enables developers to build and deploy smart contracts and applications without central authority control. Unlike Bitcoin, which primarily functions as digital currency, Ethereum operates as a programmable global computer where developers can create any type of decentralized service.   The platform hosts over $14 billion in DeFi applications with hundreds of thousands of active users across financial protocols, NFT marketplaces, and gaming platforms. Its transition to Proof of Stake in September 2022 reduced energy consumption by over 99%, addressing environmental concerns while strengthening network security.  The network operates through thousands of independent validator nodes that process transactions and execute smart contracts on the Ethereum Virtual Machine. Smart contracts are self-executing programs written in Solidity that automatically carry out agreements when conditions are met, eliminating intermediaries like banks or brokers.   Validators stake ETH as collateral to propose and validate blocks, earning rewards for honest participation while facing penalties for malicious behavior. The EIP-1559 upgrade introduced a dynamic base fee mechanism that burns ETH with each transaction, creating deflationary pressure during high network activity when more ETH is burned than issued to validators.  Vitalik Buterin proposed Ethereum in 2013, but seven co-founders helped build it, including Gavin Wood who created Solidity and the EVM technical specification, and Joseph Lubin who founded ConsenSys. The project launched in July 2015 after raising over $18 million through crowdfunding, quickly becoming the largest blockchain developer community. Major milestones include the 2020 Beacon Chain launch, the 2021 London hard fork implementing fee burning, and the 2022 Merge to Proof of Stake.   Ether (ETH) serves multiple functions: paying transaction fees (gas), staking to secure the network and earn 3-5% annual yields, serving as collateral in DeFi protocols, and purchasing NFTs and digital assets. The asset is increasingly adopted by traditional institutions, with publicly traded companies adding ETH to corporate treasuries to generate staking yields while maintaining blockchain exposure, and in 2024, the SEC approved spot Ethereum ETFs, allowing traditional investors to gain exposure through conventional brokerage accounts.  Ethereum's roadmap focuses on dramatically increasing transaction capacity to over 100,000 per second, reducing confirmation times, and enhancing decentralization while maintaining security against future threats like quantum computing.

Ethereum

Ethereum is sharply trending amid a broader crypto market dip, igniting a heated community debate over whether current price levels represent a significant buying opportunity or portend further downside. While some eagerly anticipate a rotation of capital from plummeting precious metals and highlight strong institutional inflows and staking activity, others express concern over underperformance and speculate on market manipulation.

Monad is a high-performance Layer 1 blockchain that processes 10,000 transactions per second with near-zero fees. The platform delivers high performance without compromising on security or decentralization, creating the infrastructure needed for complex applications that require high-frequency activity.  One of Monad’s key innovations lies in how it handles transaction processing. Instead of processing transactions one at a time like traditional blockchains, Monad processes multiple transactions simultaneously through parallel execution.   The system separates the agreement process from the execution process, allowing validators to first agree on which transactions to include and in what order, then having more time to execute those transactions without slowing down consensus. This approach, combined with a custom-built database called MonadDB, dramatically increases throughput while maintaining accuracy.  Monad also offers complete EVM compatibility, where applications built for Ethereum work on Monad without any code modifications, and users can connect with familiar wallets like MetaMask just as they would on Ethereum. Developers can immediately tap into Ethereum's established ecosystem of tools, libraries, and applications while benefitting from Monad’s performance improvements. The platform also runs on consumer-grade hardware rather than expensive specialized equipment, making it accessible for more people to participate in securing the network.  Monad has raised approximately 244 million dollars in total funding across multiple rounds. The company secured 19 million dollars in a seed round in February 2023 led by Dragonfly Capital, followed by a 225 million dollar Series A round in April 2024 led by Paradigm at a 3 billion dollar valuation. Other notable investors include Electric Capital, Greenoaks, Coinbase Ventures, and prominent angel investors such as Naval Ravikant.

Monad

Monad (MON) is gaining significant attention due to its rapidly expanding ecosystem, evidenced by substantial new user adoption, growing Total Value Locked (TVL), and strategic platform integrations leveraging its parallel EVM Layer 1 technology. Despite broader market volatility, the community remains highly bullish, actively discussing staking rewards and Monad's long-term potential as a foundational crypto asset.

Atlas Lithium Corp. operates as a U.S. mineral exploration and mining company with projects and properties in essentially all battery metals, including lithium, rare earths, graphite, nickel, cobalt, and titanium. The firm focuses on developing its hard-rock lithium project located in a premier pegmatitic district in Brazil Minas Gerais and Northeastern Brazil. Additionally, through subsidiaries, it participates in iron, gold, and quartzite projects and owns multiple mining concessions for gold, diamond, and industrial sand. The company was founded on December 15, 2011 and is headquartered in Minas Gerais,BR.

Atlas Lithium Corporation

Atlas Lithium is trending as a significant institutional stake from Citadel, progress on its Neves Project with permits secured and a processing plant delivered, and its subsidiary's NASDAQ listing, drive community discussion on the junior miner's potential re-rating amid an improving lithium market.

Unity Software, Inc. engages in the developing video gaming software. It also provides software solutions to create, run and monetize interactive, real-time two-dimensional and three-dimensional content for mobile phones, tablets, consoles, and augmented and virtual reality devices. Its platform is used by developers, artists, and designers to build content for gaming, film, retail, automotive, architecture, engineering, and construction industries. The company was founded by Joachim Ante and David Helgason in 2004 and is headquartered in San Francisco, CA.

Unity Software Inc

Shares of Unity Software Inc. are experiencing a significant sell-off after Google unveiled its Project Genie AI world model, igniting a heated discussion in the community over whether the new tool poses an existential threat to game engines or, as some argue, merely serves as a powerful accelerator for 3D content creation.

Xeris Biopharma Holdings, Inc. is a biopharmaceutical company, which engages in developing and commercializing products across a range of therapies. The company has three commercial products: Gvoke, Keveyis, and Recorlev. Gvoke is ready-to-use liquid glucagon for the treatment of severe hypoglycemia. Keveyis is the therapy approved in the United States to treat hyperkalemic, hypokalemic, and related variants of primary periodic paralysis (PPP). Recorlev is a cortisol synthesis inhibitor approved for the treatment of endogenous hypercortisolemia in adult patients with Cushing’s syndrome. Its product also includes Ogluo which is used for the treatment of severe hypoglycemia in adults, adolescents, and children aged 2 years and over with diabetes mellitus. The company was founded by Steven Prestrelski in 2005 and is headquartered in Chicago, IL.

Xeris Biopharma Holdings Inc

Xeris Biopharma is trending after its competitor Corcept Therapeutics received an FDA Complete Response Letter for its Cushing's syndrome drug, which the community views as a significant tailwind for Xeris's Recorlev to gain market share and accelerate revenue growth. Investors are also discussing the company's strong preliminary Q4 revenue and the anticipated Phase 3 trial for its multi-blockbuster potential drug, XP-8121.

Melania memes are digital collectibles intended to function as an expression of support for and engagement with the values embodied by the symbol MELANIA

Melania Trump

Melania Crypto is trending due to community buzz surrounding an upcoming documentary about Melania Trump, with discussions polarized between allegations of it being a pump-and-dump scam and hopes for a significant price rally.

Chainlink is the industry-standard decentralized oracle network that solves the "oracle problem" by connecting smart contracts with real-world data. Blockchains cannot access external information on their own, so Chainlink acts as a secure bridge, enabling smart contracts to react to real-world events using verified, tamper-proof data. It is widely considered one of the first decentralized oracle networks and is the market leader in bringing off-chain data on-chain.  The platform operates through a decentralized network of nodes that fetch, validate, and deliver data to smart contracts. When a contract requests information like a stock price, a committee of independent nodes retrieves and aggregates the data to reach consensus, then delivers a single trustworthy answer. Chainlink offers a suite of services including Data Feeds for asset prices, CCIP for cross-chain token transfers and messaging, Automation for triggering smart contract functions, and Proof of Reserve for verifying asset collateralization.  Chainlink has established itself as critical infrastructure for both DeFi and institutional adoption, with partnerships including Swift, Euroclear, Mastercard, UBS, ANZ, Fidelity International, and J.P. Morgan. Its institutional products include the Chainlink Runtime Environment for tokenized asset workflows, Confidential Compute for privacy-preserving computation, and the Automated Compliance Engine for embedding regulatory rules into smart contracts.  The LINK token is the native asset used to pay node operators for services, fund subscription accounts, and incentivize network security through staking. Node operators stake LINK as collateral, which can be slashed if they provide inaccurate data. Chainlink was co-founded in 2017 by Sergey Nazarov and Steve Ellis, who co-authored the white paper with Ari Juels, and raised $32 million in its September 2017 ICO.

ChainLink

Chainlink is trending as institutional adoption accelerates, driven by its new Grayscale ETF and growing utility for real-world asset tokenization and cross-chain interoperability. The community is actively debating its long-term potential as a foundational crypto asset, despite some recent price volatility.

statis crypto Watchlist

Bitcoin

Solana

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Altimmune (NASDAQ:ALT) Trading Up 7.2% - Here's What Happened

Altimmune (NASDAQ:ALT) Trading 7.2% Higher - Should You Buy...

Longevity Biotech Stocks Surge as $27 Trillion Healthcare Shift Favors Cell Restoration

Longevity Biotech Stocks Surge as $27 Trillion Healthcare Shift Favors Cell Restoration Longevity Biotech Stocks Surge as $27 Trillion Healthcare Shift Favors Cell Restoration PR Newswire VANCOUVER...

Altimmune (NASDAQ:ALT) Rating Increased to Strong-Buy at Barclays

Barclays raised shares of Altimmune to a "strong-buy" rating in a research report on Tuesday...

Altimmune (ALT) Shares Slide On $75 Million Stock Offering

Altimmune shares are tumbling on Wednesday following the company's announcement of a $75 million registered direct offering of common stock.read more...

Altimmune (NASDAQ:ALT) Shares Gap Down - Here's Why

Altimmune (NASDAQ:ALT) Shares Gap Down - Time to Sell...

<ul class="summary-bullets"><li>Wall Street remains positive ahead of the Federal Reserve’s policy decision and a slate of megacap tech earnings.</li><li>The Fed is expected to hold rates steady, but investors will be watching for Chair Jerome Powell’s press conference for clues on the longer-term rate path.</li><li>China has reportedly approved the first batch of Nvidia’s H200 AI chips for import.</li></ul>U.S. stock futures were higher early Wednesday as traders geared up for the Federal Reserve’s first policy decision of the year, as well as the first of the Magnificent Seven earnings today. Meta (META), Microsoft (MSFT), and Tesla (TSLA) are all scheduled to report results after the bell.The Fed is expected to hold interest rates steady. Investors will be watching for Chair Jerome Powell’s 2:30 PM ET press conference for policy clues for the year ahead.&nbsp;As of 3:00 a.m. ET on Wednesday, Nasdaq futures were up 0.9%, S&amp;P 500 futures and Russell 2000 futures were up 0.3%. However, the Dow futures were flat with a positive bias.&nbsp;&nbsp;Meanwhile, retail sentiment toward the&nbsp;<a href="https://stocktwits.com/symbol/SPY">SPDR S&amp;P 500 ETF (SPY)</a>, an exchange-traded fund that tracks the S&amp;P 500 Index, and the&nbsp;<a href="https://stocktwits.com/symbol/QQQ">Invesco QQQ Trust (QQQ)</a> ETF, which tracks the Nasdaq 100 Index, slipped to ‘extremely bearish’ from 'bearish’ a day ago, amid high message volumes. Both were among the top trending tickers on Stocktwits at the time of writing.&nbsp;And there’s no stopping the precious metals rally. Both gold and silver notched fresh records, with gold surging past $5200 and silver past $114.&nbsp;<a href="https://stocktwits.com/symbol/GLD/">SPDR Gold Shares ETF (GLD)</a> was among the top trending tickers on Stocktwits at the time of writing. The&nbsp;<a href="https://stocktwits.com/symbol/SLV">iShares Silver Trust (SLV)</a> also saw retail sentiment in ‘extremely bullish’ territory over the past day, with ‘extremely high’ levels of chatter.Trending Stocks To WatchNvidia (NVDA):&nbsp;China has reportedly approved the first batch of H200 AI chips for imports. This follows Jensen Huang’s visit to the region this week.&nbsp;Meta Platforms (META), Microsoft (MSFT), Tesla (TSLA), IBM (IBM): The earnings print will test whether AI infrastructure spending is generating sustainable bottom-line growth. Meanwhile, Tesla reportedly saw its new-car registrations in Europe drop 20% in December.ASML (ASML):&nbsp;Reported record Q4 bookings, doubling analyst estimates on massive AI demand.Amazon (AMZN):&nbsp;Reportedly sent an internal notice referencing ‘organizational changes,’ with expectations of further layoffs possibly emerging this week.C3.ai (AI):&nbsp;The company is reportedly in talks to be acquired by Automation Anywhere.Energy Fuels (UUUU): Roth Capital upgraded the stock to Neutral from Sell, citing supportive uranium pricing. They also upped the&nbsp;price target to $15.50 from $13. Altimmune (ALT): The company is raising $75 million by selling new shares directly to investors and plans to use the funds to pay for the upcoming Phase 3 trial of its drug for MASH (a type of chronic liver disease).Other tickers trending on Stocktwits at the time of writing included UnitedHealth Group (UNH), Richtech Robotics (RR), CoreWeave (CRWV), Movano (MOVE), among others.&nbsp; Other Catalysts To Watch On the economic front, beyond the 2:00 pm ET FOMC Decision, traders will monitor U.S. MBA Mortgage Applications and a tentative speech by President Trump this morning.&nbsp;And on the earnings radar, investors will also be watching for the quarterly reports from Starbucks (SBUX), AT&amp;T (T), GE Vernova (GEV), and General Dynamics (GD) before the markets open. Meanwhile, other than the big three (MSFT, META, TSLA),&nbsp; ServiceNow (NOW), and Wolfspeed (WOLF),&nbsp;among others, report later today.&nbsp;For updates and corrections, email newsroom[at]stocktwits[dot]com

Nasdaq, S&P 500 Futures Edge Higher Ahead Of Fed Decision, Mag 7 Earnings Kick Off: Why NVDA, ASML, ALT, AI, UUU Are On Traders' Radar Today

Retail sentiment on major ETFs such as SPY and QQQ turned ‘extremely bearish’ on Stocktwits. 

Equity

Retail sentiment on major ETFs such as SPY and QQQ turned ‘extremely bearish’ on Stocktwits. 


In this photo illustration, the Altimmune logo is seen displayed on the screen of the tablet. (Photo Illustration by Sheldon Cooper/SOPA Images/LightRocket via Getty Images)

ALT Stock Surges Toward Sixth Straight Day Of Gains: Retail Bets A Buyout Is On The Horizon

Altimmune plans to raise $75 million via a direct offering to bankroll its Phase 3 MASH trial, easing near-term funding risk.

Altimmune (NASDAQ:ALT) Trading 16.1% Higher - Should You Buy?

Altimmune (NASDAQ:ALT) Trading Up 16.1% - Should You Buy...

Stock Traders Purchase High Volume of Call Options on Altimmune (NASDAQ:ALT)

Altimmune, Inc. (NASDAQ:ALT - Get Free Report) was the target of unusually large options trading activity on Friday. Stock investors bought 14,727 call options on the stock. This represents an...

<ul class="summary-bullets"><li>Wall Street is heading into Friday on pause, despite supportive macro signals.&nbsp;</li><li>Power and grid-related names are on watch after the U.S. government reportedly requested backup power from data centers as a record-breaking winter storm threatens grid stability.</li><li>On the macro front, traders will track U.S. Services and Manufacturing PMI data before the open, followed by Consumer Sentiment at 10:00 a.m.</li></ul>U.S. stock futures&nbsp;were subdued early Friday, even as geopolitical tensions cooled and economic data remained supportive.As of 3:50 a.m. ET on Friday, the S&amp;P 500, Dow, and Russell 2000 futures were flat, while the Nasdaq 100 futures fell 0.1%.&nbsp;Meanwhile, the retail sentiment toward the&nbsp;<a href="https://stocktwits.com/symbol/SPY">SPDR S&amp;P 500 ETF (SPY)</a>, an exchange-traded fund that tracks the S&amp;P 500 Index, moderated to ‘bearish’ from 'extremely bearish,’ and the&nbsp;<a href="https://stocktwits.com/symbol/QQQ">Invesco QQQ Trust (QQQ)</a> ETF, which tracks the Nasdaq 100 Index, has remained ‘bearish,’ amid high message volumes, signaling continued caution toward tech-heavy exposure.Trending Stocks To WatchIntel (INTC): Shares will be in focus today after issuing a soft Q1 2026 outlook.Tesla (TSLA): Elon Musk announced that Robotaxi rides in Austin are now open to the public without safety monitors. He also&nbsp;said the company plans to raise the price of its $99-per-month Full Self-Driving (FSD) subscription as capabilities improve.Netflix (NFLX): Co-CEO Greg Peters has reportedly said that the company is on track to win shareholder backing for its Warner Bros. Discovery (WBD) offer, dismissing Paramount’s rival bid as failing the ‘sniff test.’Movano (MOVE): Its merger partner, Corvex, secured long-term deployment of NVIDIA H200 GPUs to support AI-driven battery technology workloads.Capital One (COF): Announced a massive $5.15 billion acquisition of startup Brex.&nbsp;Spotify (SPOT): The stock is on the retail radar after Goldman Sachs upgraded it to ‘Buy’ and the rollout of new AI-powered features.&nbsp;Oracle (ORCL): Shares jumped in overnight trading after President Trump confirmed a deal involving a U.S.-China joint venture to keep TikTok operational, with Oracle as a key investor and cloud partner.Alphabet (GOOGL): The company has failed to convince a federal judge in California to dismiss a consumer antitrust lawsuit accusing it of using restrictive agreements to maintain search dominance.&nbsp;Amazon (AMZN): The company is reportedly preparing for another round of corporate layoffs next week.Sanofi (SNY): The company will move forward with global regulatory submissions for amlitelimab following successful Phase 3 trials in atopic dermatitis.Watchout for power stocks such as Constellation Energy (CEG), Vistra (VST), and Generac (GNRC). The U.S. government has requested backup power from data centers as a record-breaking winter storm threatens the national grid.Other tickers trending on Stocktwits at the time of writing included Novo Nordisk (NVO), Altimmune (ALT), and Ascent Solar Technologies (ASTI). Other Catalysts To Watch On the economic front, traders will be monitoring the release of U.S. Services &amp; Manufacturing PMI prints before markets open and Consumer Sentiment data, due at 10:00 am ET.&nbsp;And on the earnings radar, investors will be watching for the quarterly reports from Maxeon Solar Technologies (MAXN), and SLB,&nbsp;among others, later today.&nbsp;For updates and corrections, email newsroom[at]stocktwits[dot]com

Nasdaq, S&P 500 Futures Subdued Ahead Of PMI Data: Why INTC, TSLA, NFLX, VST, MOVE Are On Traders' Radar Today

Retail sentiment on Stocktwits for SPY and QQQ remained ‘bearish’.

Altimmune, Inc. is a clinical stage biopharmaceutical company, which focuses on the development of novel peptide-based therapeutics for the treatment of obesity and liver diseases. The company's lead product candidate, pemvidutide, is a GLP-1/glucagon dual receptor agonist that is being developed for the treatment of obesity and NASH. In addition, Altimmune is developing HepTcell, an immunotherapeutic designed to achieve a functional cure for chronic hepatitis B. The company was founded in 1997 and is headquartered in Gaithersburg, MD.

Altimmune Inc

Beat EPS and revenue

Beat EPS, miss revenue

Miss EPS, beat revenue

Miss EPS and revenue

Stocktwits

Palantir Technologies Inc

Stocktwits Polls

Traders speculate on a potential buyout or major partnership with Sanofi following the discovery of new pharmaceutical trademark filings that align with ALT's drug pipeline.

The stock displayed remarkable resilience and finished significantly up on a day when the broader market experienced widespread declines.

A significant new institutional investor has acquired a large stake, and Vanguard has substantially increased its position, signaling strong institutional confidence.

Community members are frequently dismissing and mocking a prominent user's bearish claims against ALT, especially in light of that user's recent losses on other stocks.

Fiscal Period	Estimated	Reported	Surprise	Result
Q4 '25	-$0.23	--	--	N/A
Q3 '25	-$0.27	-$0.21	22.83%	BEAT
Q2 '25	-$0.34	-$0.27	19.70%	BEAT
Q1 '25	-$0.35	-$0.26	26.12%	BEAT
Q4 '24	-$0.33	-$0.33	0.75%	BEAT

ALT
Altimmune Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q4 '25

Historical Earnings

Latest ALT News

ALTAltimmune Inc